$NVDA NEWS Nvidia stock tumbles as new Biden rule threatens new curbs on chip exports Munich - Delayed Quote • EUR Vidhance AB N (8W50.MU) Follow Compare 0.5740 0.0000 (0.00%) As of 8:08:24 AM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 8W50.MU 1D 5D 0.00% 1M 0.00% 3M -18.70% 6M -41.43% YTD -9.18% 1Y -36.22% 5Y -94.14% All -94.14% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Why U.S. Steel Stock Soared Today BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps. Why Fertilizer Makers, Including NTR and CF, Are Climbing Today Stock Market Today: Dow Jones Up, But 2024 Winner Gets Hammered; Bitcoin Loses $92,000 Level (Live Coverage) Cleveland-Cliffs and Nucor Mull Fresh Bid for U.S. Steel Cleveland-Cliffs and Nucor Consider Joint US Steel Bid The Nasdaq and the S&P 500 slump as Biden's new AI rules rattle Nvidia and other tech stocks Moderna Crashes 21%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall. These Stocks Are Moving the Most Today: Nvidia, Micron, Moderna, Intra-Cellular Therapies, D-Wave Quantum, Edison, U.S. Steel, and More Abercrombie and Fitch (ANF) Stock Trades Down, Here Is Why Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why